Positive direct antiglobulin test in COVID-19 patients: Decision-making process
Autor: | Pascale Saussoy, J. Cabo, Véronique Deneys, A. Brochier, L. Capirchio, B. Delire, M.-A. van Dievoet |
---|---|
Přispěvatelé: | UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de biologie hématologique, UCL - (SLuc) Service de gastro-entérologie |
Rok vydání: | 2021 |
Předmět: |
elution
Clinical Biochemistry 030204 cardiovascular system & hematology Serology Ag Antigen 0302 clinical medicine DAT Direct Antiglobulin Test PCR Polymerase Chain Reaction Direct antiglobulin test RBCs Red Blood Cells IAS Irregular Antibody Screening biology Hematology CRP C-Reactive Protein IAT Indirect Antiglobulin Test Coombs Test COVID-19 Coronavirus Disease 2019 Antibody Nl normal 2019-20 coronavirus outbreak medicine.medical_specialty Coronavirus disease 2019 (COVID-19) ECMO Extracorporeal Membrane Oxygenation Coombs direct Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Context (language use) AHG Anti-Human Globulin Ab Antibody direct antiglobulin test élution Article 03 medical and health sciences AIHA Autoimmune Haemolytic Anaemia IAHA Immuno-Allergic Haemolytic Anaemia ICU Intensive Care Unit SOP Standard Operating Procedure medicine Humans Blood Transfusion Intensive care medicine transfusion SARS-CoV-2 business.industry Transfusion Biochemistry (medical) COVID-19 Elution SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 CAS Cold Agglutinin Syndrome biology.protein business 030215 immunology |
Zdroj: | Transfusion Clinique et Biologique Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, Vol. 28, no.4, p. 414-419 (2021) |
ISSN: | 1246-7820 |
DOI: | 10.1016/j.tracli.2021.05.010 |
Popis: | In this unprecedented crisis of severe acute respiratory syndrome coronavirus 2 and its associated coronavirus disease 2019 (COVID-19), polymerase chain reaction and then serological testing platforms have been massively developed to face the important screening demand. Polymerase chain reaction and serological testing platforms are not the only actors impacted by the crisis, transfusion services are facing important difficulties. A positive direct antiglobulin test is frequently observed for patients encountering COVID-19. Patients with severe symptoms may develop anaemia and become good candidates for blood transfusions. The interpretation of a positive direct antiglobulin test for patients recently transfused and suffering from COVID-19 is complex. The differentiation between COVID-19 induced antibodies and possible associated transfusion alloantibodies is therefore crucial. In this context, the elution technique incorporated in an appropriate decision-making process plays its full role. This intricate topic is presented through a case report followed by literature review and finally decision-making process for COVID-19 patients necessitating red blood cells administration. |
Databáze: | OpenAIRE |
Externí odkaz: |